Current report no. 2020/11/1

The BS Biotechna S.A. project entitled “BS2020 – Research and development of a new medicinal product for the treatment of cancer” has received a positive recommendation for co-financing by the National Centre for Research and Development (NCBiR) under the Intelligent Development Operational Programme 2014-2020, measure 1.1/sub-measure 1.1.1. The aim of the project is to create an innovative drug for use in molecularly targeted cancer therapy and to confirm its effectiveness in breast cancer. The total cost of the project is PLN 41,901,795.00, with funding amounting to PLN 32,080,426.80. Implementation period: 1 April 2021 – 30 November 2023.

Link